RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL)

Clinical trials for RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL) explained in plain language.

Never miss a new study

Get alerted when new RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL) trials appear

Sign up with your email to follow new studies for RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Last-Hope drug offered to patients with untreatable lymphoma

Disease control AVAILABLE

This program provides access to an experimental drug called odronextamab for patients with specific types of aggressive B-cell lymphoma that have returned or not responded to standard treatments. It is for people who have run out of approved treatment options. The goal is to try …

Matched conditions: RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL)

Sponsor: Regeneron Pharmaceuticals • Aim: Disease control

Last updated Apr 04, 2026 03:21 UTC

RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL)

Get alerted when new RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL) trials appear

Last-Hope drug offered to patients with untreatable lymphoma